TenNor Therapeutics 1H FY26 loss narrows 17.81% to RMB 64.25 millionPUBT·Aug 26 at 04:05 AM06872-0.16%
Weekly Recap | TENNOR THERAP-B -4.48%, interim results next weekWeekly Review·Aug 21 at 11:20 PM06872-0.16%
TenNor Therapeutics schedules board meeting to review interim results, consider dividendPUBT·Aug 14 at 03:33 AM06872-0.16%
Dynavax Technologies climbs 3% in Hong Kong tradingHK Stock Market Update·Jun 7 at 09:11 PM06872-0.16%
Novel Gastric Drug Hopes Fuel Strong Hong Kong Debut For Biotech Firmbenzinga_article·May 28 at 08:29 AM06872-0.16%
The first new drug for Helicobacter pylori in 40 years is in hand, and TENNOR THERAP is favored by the marketBambooWorks·May 27 at 07:55 PM06872-0.16%
News: Oversubscription exceeded 9,000 times, TENNOR THERAP-B doubled on the first day of tradingBambooWorks·May 21 at 11:35 PM06872-0.16%
